UD RESEARCH INITIATIVE
BIOPHARMACEUTICALS
ADVANCING MODERN MEDICINES
Biopharmaceutical Innovation
“UD is an emerging leader in the exciting field of biopharmaceutical research. Building on our University’s rich legacy, today’s innovators — our students and faculty — are shaping the front lines of discovery.”

Dennis Assanis
President, University of Delaware

Biopharmaceuticals are revolutionizing medicine. These treatments, which rely on living cells for their production, have been crucial in helping the world gain the upper hand in the battle against COVID-19. Other biopharmaceuticals are highly effective in treating and preventing cancer, diabetes, autoimmune disorders, and bacterial and viral infections. The University of Delaware is pursuing high-tech research to develop these life-saving therapies and advance their manufacturing.
Partnering for progress
The University of Delaware is a major economic engine for Delaware and the entire Northeast Corridor, supporting thousands of jobs far beyond our campus and fueling the region’s competitive edge in the global innovation economy. Discover the possibilities.
Innovation with Impact
2020 Biopharma Market Value
Medicines Currently in Development Around the World
%
Of Medicines in Dev have a Potential to be First-in-Class Treatments
Supports Over 4 Million Jobs Across the Country
Source: PhRMA — 2020 Biopharmaceutical Industry Profile
Biopharmaceutical Discovery, Innovation and Collaboration
The Ammon Pinizzotto Biopharmaceutical Innovation Center is the scientific epicenter for UD’s biopharmaceutical science initiative. The state-of-the-art facility brings together academia, industry and government to create an interdisciplinary hub of discovery, innovation and industrial practices based on a collaborative approach. It is also home to the National Institute for Innovation in Manufacturing Biopharmaceuticals — NIIMBL — leveraging UD’s foundation of impactful partnerships to address the grand challenges of health care, medicine and biopharmaceutical manufacturing.
Related Departments, Centers and Institutes
Department of Chemical and Biomolecular Engineering
Department of Biomedical Engineering
Department of Biological Sciences
Department of Chemistry and Biochemistry
Department of Medical and Molecular Sciences
Delaware Biotechnology Institute
Data Science Institute
Center for Biomanufacturing Science and Technology
National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Take a Virtual Tour
Explore the Ammon Pinizzotto Biopharmaceutical Innovation Center at UD’s STAR Campus by scrolling left, right, top and bottom, to discover what makes this facility so unique.
Loading...
Loading...
Biopharma News
The University of Delaware research community is applying its expertise to develop health care solutions using biopharmaceuticals. Check back frequently for updates.
Kristi Kiick Honored for Inventions
UD engineering professor honored by National Academy of Inventors
Leading the Way in Biopharmaceuticals
Thought leaders explore emerging area of biotherapeutics
Major Step for Biopharma Research
NIIMBL and FDA sign agreement to support innovation in biopharma manufacturing
Biotechnology Innovation Hub
Global experts visit UD to learn about biotech ecosystem
Governor Carney tours biopharmaceutical building site
Part of UD’s STAR Campus, the facility will be a center for research on producing complex medication
Recognition for biotechnology influencer
Kelvin Lee receives Marvin J. Johnson Award in Microbial and Biochemical Technology
Hitchhikers hinder medication shelf life
UD ingenuity sheds light on key biopharmaceutical manufacturing problem
A NIIMBL Approach To Making Modern Medicines
Biopharmaceuticals have emerged recently and are having a revolutionary impact on vexing diseases such as cancer. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), headquartered at the University of Delaware, is at the forefront of making medicines more accessible to Americans.
Building the future with biopharmaceuticals
UD’s McCandless and collaborators find path to higher efficiency, lower cost
University of Delaware
A Leader in Biopharma
Biopharmaceutical Manufacturing Innovation
Biomedical Research Excellence
World-Class Facilities
UD’s newest research facility is the Ammon Pinizzotto Biopharmaceutical Innovation Center, which opened at STAR Campus in 2020. Within this state-of-the-art facility, you’ll find NIIMBL’s headquarters, the Delaware Biotechnology Institute, UD’s renowned Bio-Imaging Center, laboratories and classrooms.
Partner with us!
We welcome partners who see the value in collaborating with our world-class faculty, providing experiential learning opportunities for our students and employing our graduates. Contact us today!
ASSISTANCE
Compliance Hotline
Phone: (302) 831-2792
Research Administration
Phone: (302) 831-2136
Fax: (302) 831-2828
HOURS OF OPERATION
The University of Delaware Research Office is open from 8 a.m. to 5 p.m. Monday through Friday. The Research Office is closed Saturday and Sunday and observes all University closings and holidays. See the Academic Calendar for more information.